Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ 8-K - Current report Filed: 2018-11-19 AccNo: 0001193125-18-329463 Size: 47 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-07 AccNo: 0001564590-18-027565 Size: 10 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2018-11-06 AccNo: 0001564590-18-027430 Size: 8 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 美东时间 2018-11-06 盘后 披露财报,预期EPS 0.22 网页链接
$万基遗传(MYGN)$ 8-K/A [Amend] - Current report Filed: 2018-10-15 AccNo: 0001193125-18-298584 Size: 957 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-10-10 AccNo: 0001193125-18-296460 Size: 68 KB 网页链接
$万基遗传(MYGN)$ DEF 14A - Other definitive proxy statements Filed: 2018-10-10 AccNo: 0001193125-18-296456 Size: 1 MB 网页链接
$万基遗传(MYGN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-08-24 AccNo: 0001564590-18-022312 Size: 31 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2018-08-21 AccNo: 0001564590-18-022125 Size: 8 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 美东时间 2018-08-21 盘后 披露财报,预期EPS 0.33 网页链接